AeroVironment Inc

AVAV

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 319,833Value: $77.4M

**Signal Note: Driehaus Capital initiates $77.4M position in AeroVironment (AVAV)** This is a commercial drone/robotics play, not biotech—AVAV manufactures unmanned aircraft systems for defense, commercial, and government applications. The position likely reflects conviction in near-term defense spending tailwinds or potential M&A activity rather than clinical/regulatory catalysts. Biotech-focused growth managers occasionally diversify into adjacent deep-tech; this may indicate portfolio rebalancing or conviction in AVAV's autonomous systems competitive moat.

More AVAV Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: